Compare · CRON vs RGC
CRON vs RGC
Side-by-side comparison of Cronos Group Inc. (CRON) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRON and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.62B, about 2.1x CRON ($1.22B).
- Over the past year, CRON is up 28.2% and RGC is down 57.8% - CRON leads by 85.9 points.
- CRON has hit the wire 6 times in the past 4 weeks while RGC has been quiet.
- CRON has more recent analyst coverage (11 ratings vs 0 for RGC).
- Company
- Cronos Group Inc.
- Regencell Bioscience Holdings Limited
- Price
- $3.32+3.11%
- $5.26-3.40%
- Market cap
- $1.22B
- $2.62B
- 1M return
- +21.39%
- -7.15%
- 1Y return
- +28.19%
- -57.75%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 6
- 0
- Recent ratings
- 11
- 0
Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Latest CRON
- SEC Form 4 filed by Director Garnick Murray R
- SEC Form 4 filed by Director Rudyk James Daniel
- SEC Form 4 filed by Director Adler Jason Marc
- Amendment: Cronos Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by Cronos Group Inc.
- Cronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
- Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026
- Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada
- SEC Form 3 filed by new insider Broughton Darren Chester
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited